once monthly glp 1 MariTide: The GLP-1 That Says ‘Nope’ to GIP | Dr. Dan ADA 2026 confirmed what many
Description
The FDA flagged marketing claims suggesting that compounded GLP-1s shared the same safety and efficacy profiles as their branded counterparts, noting that such labeling can mislead consumers and violate the Food, Drug, and Cosmetic Act
Amount Per Serving
Scientist-formulated, non-GMO, and made for consistent, everyday supplementation
Compounders were expected to cease production of tirzepatide by March 2025 and semaglutide by May 2025, yet both remain active in the market
GLP-1s gave me more food flexibility and energy
